Fortress Biotech Inc (FBIO)
1.49
+0.04
(+2.76%)
USD |
NASDAQ |
Sep 27, 16:00
1.455
-0.04
(-2.35%)
Pre-Market: 20:00
Fortress Biotech Accounts Receivable (Quarterly): 10.46M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 10.46M |
March 31, 2024 | 9.799M |
December 31, 2023 | 15.22M |
September 30, 2023 | 7.989M |
June 30, 2023 | 16.74M |
March 31, 2023 | 27.62M |
December 31, 2022 | 28.21M |
September 30, 2022 | 28.53M |
June 30, 2022 | 28.67M |
March 31, 2022 | 31.18M |
December 31, 2021 | 23.11M |
September 30, 2021 | 31.74M |
June 30, 2021 | 26.19M |
March 31, 2021 | 19.44M |
December 31, 2020 | 23.93M |
September 30, 2020 | 15.65M |
June 30, 2020 | 11.17M |
March 31, 2020 | 15.81M |
Date | Value |
---|---|
December 31, 2019 | 13.54M |
September 30, 2019 | 5.137M |
June 30, 2019 | 3.104M |
March 31, 2019 | 8.022M |
December 31, 2018 | 5.498M |
September 30, 2018 | 5.431M |
June 30, 2018 | 5.321M |
March 31, 2018 | 8.314M |
December 31, 2017 | 7.758M |
September 30, 2017 | 5.582M |
June 30, 2017 | 3.336M |
March 31, 2017 | 1.368M |
December 31, 2016 | 1.83M |
September 30, 2016 | 5.007M |
June 30, 2016 | 0.967M |
March 31, 2016 | |
December 31, 2015 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
5.137M
Minimum
Sep 2019
31.74M
Maximum
Sep 2021
19.51M
Average
18.09M
Median
Accounts Receivable (Quarterly) Benchmarks
Checkpoint Therapeutics Inc | -- |
Journey Medical Corp | 10.46M |
Avenue Therapeutics Inc | -- |
Phathom Pharmaceuticals Inc | 10.88M |
NovaBay Pharmaceuticals Inc | 0.547M |